Intracerebroventricular neuropeptide Y suppresses open field and home cage activity in the rat
- PMID: 3432602
- DOI: 10.1016/0167-0115(87)90278-3
Intracerebroventricular neuropeptide Y suppresses open field and home cage activity in the rat
Abstract
Effects of intracerebroventricular administration of neuropeptide Y on open field behaviour, behavioural habituation and corticosterone response to open field testing, and on home cage activity have been investigated in the rat. In the open field, NPY reduced activity in a dose-dependent manner. Behavioural habituation was not influenced. After 5 days of recovery, NPY-treated animals did not differ from non-treated in any of the measured parameters. Peripheral corticosterone levels were not significantly affected, although there was a strong tendency towards an increase. Injection of 2 nmol NPY did not produce any gross neurological deficits. At this dose, NPY greatly suppressed home cage activity. The effect lasted throughout the recording period of 22 h, abolishing the normal circadian variation in activity. After 5 days of recovery, the effect was no longer present. Our interpretation of these findings is, that NPY is a highly potent endogenous agent capable of producing certain important aspects of behavioural sedation in a reversible manner. Since NPY did not decrease the corticosterone response to a novel stimulus, its pattern of actions seems to differ from synthetic sedative drugs.
Similar articles
-
Intracerebroventricular neuropeptide Y protects against stress-induced gastric erosion in the rat.Eur J Pharmacol. 1987 May 7;137(1):127-9. doi: 10.1016/0014-2999(87)90191-9. Eur J Pharmacol. 1987. PMID: 3609132
-
Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation.J Neurosci Res. 2004 Sep 1;77(5):723-9. doi: 10.1002/jnr.20200. J Neurosci Res. 2004. PMID: 15352219
-
Intracerebroventricular administration of neuropeptide Y affects parameters of dopamine, glutamate and GABA activities in the rat striatum.Brain Res Bull. 1992 Feb;28(2):187-93. doi: 10.1016/0361-9230(92)90178-z. Brain Res Bull. 1992. PMID: 1596740
-
Inhibition of amphetamine- and apomorphine-induced behavioural effects by neuropeptide Y Y(1) receptor antagonist BIBO 3304.Neuropharmacology. 2000 Apr 27;39(7):1292-302. doi: 10.1016/s0028-3908(99)00199-9. Neuropharmacology. 2000. PMID: 10760371
-
The effects of central administration of neuropeptide Y on behavior, neurotransmitter, and immune functions in the olfactory bulbectomized rat model of depression.Brain Behav Immun. 1996 Mar;10(1):1-16. doi: 10.1006/brbi.1996.0001. Brain Behav Immun. 1996. PMID: 8735565
Cited by
-
Centrally administered neuropeptide Y (NPY) inhibits gastric emptying and intestinal transit in the rat.Dig Dis Sci. 1993 May;38(5):845-50. doi: 10.1007/BF01295910. Dig Dis Sci. 1993. PMID: 8482183
-
Effects of centrally administered neuropeptide Y (NPY) and NPY13-36 on the brain monoaminergic systems of the rat.J Neural Transm Gen Sect. 1990;79(3):193-208. doi: 10.1007/BF01245130. J Neural Transm Gen Sect. 1990. PMID: 2297403
-
Neuropeptide Y in Alcohol Addiction and Affective Disorders.Front Endocrinol (Lausanne). 2017 Jul 31;8:178. doi: 10.3389/fendo.2017.00178. eCollection 2017. Front Endocrinol (Lausanne). 2017. PMID: 28824541 Free PMC article. Review.
-
Corticotropin-releasing factor (CRF) and neuropeptide Y (NPY): effects on inhibitory transmission in central amygdala, and anxiety- & alcohol-related behaviors.Alcohol. 2012 Jun;46(4):329-37. doi: 10.1016/j.alcohol.2011.11.009. Epub 2012 May 4. Alcohol. 2012. PMID: 22560367 Free PMC article. Review.
-
Neuropeptide Y Regulates Sleep by Modulating Noradrenergic Signaling.Curr Biol. 2017 Dec 18;27(24):3796-3811.e5. doi: 10.1016/j.cub.2017.11.018. Epub 2017 Dec 7. Curr Biol. 2017. PMID: 29225025 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous